688046 logo

GemPharmatech Co., Ltd. Stock Price

SHSE:688046 Community·CN¥6.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

688046 Share Price Performance

CN¥15.36
2.88 (23.08%)
CN¥15.36
2.88 (23.08%)
Price CN¥15.36

688046 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet second-rate dividend payer.

1 Risk
2 Rewards

GemPharmatech Co., Ltd. Key Details

CN¥752.7m

Revenue

CN¥283.1m

Cost of Revenue

CN¥469.5m

Gross Profit

CN¥348.0m

Other Expenses

CN¥121.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 23, 2026
0.30
62.38%
16.14%
11.6%
View Full Analysis

About 688046

Founded
2017
Employees
1578
CEO
Jing Zhao
WebsiteView website
www.gempharmatech.com

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.

Recent 688046 News & Updates

Recent updates

No updates